GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Other Gross PPE

Lavipharm (ATH:LAVI) Other Gross PPE : €-0.00 Mil (As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Other Gross PPE?

Lavipharm's Other Gross PPE for the quarter that ended in Jun. 2024 was €-0.00 Mil.

Lavipharm's quarterly Other Gross PPE declined from Jun. 2023 (€0.52 Mil) to Dec. 2023 (€0.49 Mil) and declined from Dec. 2023 (€0.49 Mil) to Jun. 2024 (€-0.00 Mil).

Lavipharm's annual Other Gross PPE declined from Dec. 2021 (€2.47 Mil) to Dec. 2022 (€0.52 Mil) and declined from Dec. 2022 (€0.52 Mil) to Dec. 2023 (€0.49 Mil).


Lavipharm Other Gross PPE Historical Data

The historical data trend for Lavipharm's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Other Gross PPE Chart

Lavipharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial - - 2.47 0.52 0.49

Lavipharm Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 9.95 0.52 0.52 0.49 -

Lavipharm Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Lavipharm Business Description

Traded in Other Exchanges
Address
Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002
Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm Headlines

No Headlines